StoneX Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
StoneX Group's NVS Position: Q2 2026 in Review
StoneX Group opened a new position in Novartis (NVS) in Q2 2026: 2,818 shares worth $430K. The stake represents 0.02% of the portfolio and ranks #635 among its holdings. This is a return to the name: StoneX Group previously reported a position in NVS as recently as Q4 2025.
StoneX Group first reported a position in NVS in Q4 2016 and has held it in 16 quarters since. The position peaked at $8.6M in Q3 2021. 1,618 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- StoneX Group held 2,818 shares of Novartis worth $430K as of Q2 2026.
- Novartis was a new StoneX Group position in Q2 2026.
- Novartis made up 0.02% of StoneX Group's portfolio in Q2 2026, its #635 holding.
- StoneX Group first reported a position in Novartis in Q4 2016 and has held it in 16 quarters since.
- StoneX Group's Novartis position peaked at $8.6M in Q3 2021.
- 1,618 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.